A Leap into the Future: Assistant Professor Michael Garton on the promise of synthetic biology
The Leap into the Future series looks at emerging areas or aspects of regenerative medicine.
The Leap into the Future series looks at emerging areas or aspects of regenerative medicine.
Can turning off genetic switches in therapeutic cells help them avoid attack from the immune system?
$430,000 investment to study if a type of immune cell could be the key to transplanting insulin-producing cells for diabetes treatment
This “revolutionizing biology” offers the promise of new treatments for diseases and conditions including inflammatory bowel disease and autism spectrum disorder.
Researchers say the findings lay groundwork that could lead to methods for expanding stem cell numbers from donated cord blood biobanks to improve availability for people with leukemia.
Can we make lung transplants a thing of the past?
Can nanotechology prevent a silent killer?
An interdisciplinary team of scientists, funded by Medicine by Design, aims to use retinal stem cells to restore vision.